Burcon NutraScience Corporation (TSX:BU)
Canada · Delayed Price · Currency is CAD 2.300
0.00 (0.00%)
Jun 12, 2026, 11:53 AM EST
Burcon NutraScience Balance Sheet
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 1.29 | 7.28 | 4.2 | 1.46 | 7 | 13.97 |
Cash & Short-Term Investments | 1.29 | 7.28 | 4.2 | 1.46 | 7 | 13.97 |
Cash Growth | 117.81% | 73.36% | 188.10% | -79.19% | -49.90% | -7.04% |
Other Receivables | 0.48 | 0.13 | 0.59 | 0.33 | 0.2 | 0.34 |
Total Trade Receivables | 0.48 | 0.13 | 0.59 | 0.33 | 0.2 | 0.34 |
Inventory | 0.82 | 0.2 | 0.07 | - | - | 0.13 |
Other Current Assets | 0.34 | 0.19 | 0.33 | 0.08 | 0.41 | 0.15 |
Total Current Assets | 2.7 | 7.8 | 5.19 | 1.86 | 7.62 | 14.6 |
Net Property, Plant & Equipment | 14.3 | 15.8 | 1.1 | 0.98 | 0.86 | 1.01 |
Other Intangible Assets | 4.64 | 4.95 | 5.37 | 5.8 | 6.22 | 4.46 |
Goodwill | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 |
Long-Term Investments | - | - | - | - | 13.4 | 16.4 |
Other Long-Term Assets | 0.86 | 0.85 | - | - | - | - |
Total Assets | 23.97 | 30.66 | 12.91 | 9.9 | 29.35 | 37.72 |
Accounts Payable | 2.19 | 1.27 | 0.84 | 0.59 | 0.91 | 1.42 |
Current Portion of Long-Term Debt | 8.36 | 2.09 | - | - | - | - |
Current Portion of Leases | 1.84 | 0.89 | 0.26 | 0.03 | 0.01 | 0.03 |
Unearned Revenue | - | 0.05 | 0.25 | - | 0.12 | - |
Total Current Liabilities | 12.39 | 4.29 | 1.35 | 0.63 | 1.04 | 1.45 |
Long-Term Debt | 0.68 | 5.79 | 6.4 | 5.11 | - | - |
Long-Term Leases | 13.39 | 13.63 | - | 0.02 | 0.06 | 0.01 |
Total Long-Term Liabilities | 14.07 | 19.42 | 6.4 | 5.14 | 0.06 | 0.01 |
Total Liabilities | 26.46 | 23.71 | 7.76 | 5.76 | 1.1 | 1.45 |
Common Stock | 131.61 | 131.58 | 122.07 | 114.57 | 114.57 | 114.11 |
Additional Paid-in Capital | 26.78 | 25.67 | 25.13 | 24.17 | 22.92 | 21.14 |
Accumulated Other Comprehensive Income | 0.08 | 0 | - | - | - | - |
Retained Earnings | -160.97 | -150.31 | -142.05 | -134.6 | -109.24 | -98.98 |
Shareholders' Equity | -2.49 | 6.94 | 5.15 | 4.14 | 28.25 | 36.27 |
Total Liabilities & Equity | 23.97 | 30.66 | 12.91 | 9.9 | 29.35 | 37.72 |
Total Debt | 24.27 | 22.4 | 6.67 | 5.17 | 0.07 | 0.03 |
Net Cash (Debt) | -22.98 | -15.12 | -2.47 | -3.71 | 6.93 | 13.94 |
Net Cash Growth | - | - | - | - | -50.30% | 67.95% |
Net Cash Per Share | -1.81 | -1.19 | -0.35 | -0.67 | 1.28 | 4.51 |
Book Value | -2.49 | 6.94 | 5.15 | 4.14 | 28.25 | 36.27 |
Book Value Per Share | -0.20 | 0.55 | 0.73 | 0.75 | 5.20 | 11.75 |
Tangible Book Value | -8.38 | 0.74 | -1.48 | -2.91 | 20.78 | 30.55 |
Tangible Book Value Per Share | -0.66 | 0.06 | -0.21 | -0.53 | 3.83 | 9.90 |